The Journal of Experimental Medicine · 1996 · 925 citations · 23 references
Life SciencesCell BiologyImmunologyApoptosisCellular ImmunologyImmunoregulationApoptosis In Immune CellsImmune Checkpoint InhibitorsLymphocyte ActivationT Cell ActivationT Cell Activation ControlT Cell BiologyCd28 CostimulationCd28 SignalingCell ActivationCell Cycle DynamicsCell Cycle InhibitionCtla-4 InhibitionCtla-4-mediated RegulationCytotoxic T-lymphocyte Antigen 4 (Ctla-4) Pathway
While interactions between CD28 and members of the B7 family costimulate and enhance T cell responses, recent evidence indicates that the CD28 homologue CTLA-4 plays a downregulatory role. The mechanism by which this occurs is not clear, but it has been suggested that CTLA-4 terminates ongoing responses of activated T cells, perhaps by induction of apoptosis. Here we demonstrate that CTLA-4 engagement by antibody cross-linking or binding to B7 inhibits proliferation and accumulation of the primary T cell growth factor, IL-2, by cells stimulated with anti-CD3 and anti-CD28. This inhibition is not a result of enhanced cell death. Rather it appears to result from restriction of transition from the G1 to the S phase of the cell cycle. Our observation that upregulation of both the IL-2R alpha chain and the CD69 activation antigen are inhibited by CTLA-4 engagement supplies further evidence that CTLA-4 restricts the progression of T cells to an activated state. Together this data demonstrates that CTLA-4 can regulate T cell activation in the absence of induction of apoptotic cell death.
23
CTLA-4 can function as a negative regulator of T cell activation
Theresa L. Walunas, Deborah J. Lenschow, Christina Y. Bakker et al. · Immunity · 1994 · 2.2K citations
CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-xL
Lawrence Boise, Andy J. Minn, Patricia J. Noel et al. · Immunity · 1995 · 1.2K citations · Full text